TERT and central nervous system cancer: The triple-positive group had favorable prognosis, whereas the TERT mutation group had a dismal survival expectancy (Figure 1D, univariate analysis in Supplementary Table 2), although this relationship was not found for Grade IV gliomas (Figure 1E, Supplementary Table 5).